Profilo
Lida Pacaud is currently Chief Executive & Medical Officer at Ichnos Glenmark Innovation, Inc. starting in 2025.
Formerly, Dr. Pacaud was Vice President-Clinical Development at Legend Biotech Corp.
from 2021 to 2023 and Head-Global Clinical Program at Novartis International AG from 2013 to 2021.
Education includes a doctorate from Tbilisi State Medical University.
Posizioni attive di Lida Pacaud
| Società | Posizione | Inizio |
|---|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Amministratore Delegato | 06/12/2025 |
Precedenti posizioni note di Lida Pacaud
| Società | Posizione | Fine |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/06/2023 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/01/2021 |
Formazione di Lida Pacaud
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Tbilisi State Medical University
Tbilisi State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















